Showing results (171-180 of 4,868) with videos related to
Sort By:
Pageof 487
Urologic Oncology|December 23, 2019
Operative and oncological results and impact on treatment strategy of systematic renal tumor biopsy: Comparison between patients 75 years oldAlexis Santy, Victor Basset, Loïc Colleter, et al.Urologic Oncology|December 23, 2019
Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patientsHiroaki Suzuki, Masaya Ito, Kosuke Takemura, et al.Urologic Oncology|November 23, 2019
Cribriform pattern and perineural invasion on MR/US fusion biopsy predict failure of selection criteria for prostatic hemigland ablationPrabhakar Mithal, Matthew Truong, Scott Quarrier, et al.Urologic Oncology|November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomyVignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.Urologic Oncology|December 9, 2019
Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsyTing-Shuai Zhai, Liang Jin, Lan-Ting Hu, et al.Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.Urologic Oncology|February 11, 2020
Risk stratification metrics for bladder cancer: Comprehensive Geriatric AssessmentsAdam J Gadzinski, Sarah P PsutkaUrologic Oncology|February 24, 2020
External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomyTimo F W Soeterik, Harm H E van Melick, Lea M Dijksman, et al.Urologic Oncology|January 19, 2020
Opportunistic prostate cancer screening: A population-based analysisBashar Matti, Kamran Zargar-ShoshtariUrologic Oncology|January 19, 2020
Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?Isabel Heidegger, Maximilian P Brandt, Matthias M HeckPageof 487